V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 310010338 | 310003810 | 1.82 | 92 | Palliative (P) | 2018-10-03 | 2018-10-12 | Liposomal Doxorubicin 40mg/m2 | N | null | 310007651 | LIPOSOMAL DOXORUBICIN |
| 310010339 | 310007560 | 1.82 | 112 | Curative (C) | 2014-01-13 | 2014-01-18 | CHOP - 21 days | N | null | 310007651 | CHOP |
| 310010340 | 310003814 | 1.76 | 74.9 | Curative (C) | 2013-10-07 | 2013-11-05 | CHOP - 21 days | 2 | null | 310007688 | CHOP |
| 310010341 | 310011177 | 1.7 | null | Neo-adjuvant (N) | 2017-09-02 | 2018-07-19 | Bevacizumab | 02 | N | 310007714 | BEVACIZUMAB |
| 310010342 | 310003817 | 1.84 | null | Palliative (P) | 2017-06-04 | 2017-10-10 | Liposomal Doxorubicin (Caelyx) | N | N | 310007768 | LIPOSOMAL DOXORUBICIN |
| 310010343 | 310003821 | 1.76 | 127.2 | Disease modification (D) | 2014-05-10 | 2014-05-11 | Liposomal Doxorubicin 40mg/m2 | N | N | 310007769 | LIPOSOMAL DOXORUBICIN |
| 310010345 | 310003828 | 1.72 | 76 | Disease modification (D) | 2018-09-18 | 2018-09-18 | Liposomal Doxorubicin 50mg/m2 | N | N | 310007894 | LIPOSOMAL DOXORUBICIN |
| 310010346 | 310003832 | 1.64 | 68 | Disease modification (D) | 2015-08-22 | 2015-09-26 | Trial Unspecified | Y | N | 310007900 | TRIAL |
| 310010347 | 310007572 | 1.65 | 85 | Neo-adjuvant (N) | null | 2018-05-12 | CARBOPLATIN + GEMCITABINE | 02 | N | 310007919 | GEMCARBO |
| 310010348 | 310003836 | 1.84 | 65 | Palliative (P) | 2018-01-31 | 2018-02-05 | GemCarbo Days 1+8 | N | N | 310007940 | GEMCARBO |
| 310010349 | 310003842 | 1.7 | 102.2 | Palliative (P) | 2014-08-12 | 2014-08-14 | GemCarbo Days 1+8 | 2 | null | 310008039 | GEMCARBO |
| 310010350 | 310007578 | 1.52 | 78 | Palliative (P) | null | 2016-09-16 | CHOP - 21 days | 02 | N | 310008048 | CHOP |
| 310010352 | 310003846 | 1.73 | 71.6 | Curative (C) | null | 2015-09-01 | GEMCARBO | N | null | 310008072 | GEMCARBO |
| 310010354 | 310010591 | 1.8 | 89 | null | 2013-10-15 | 2014-01-11 | CHOP - 21 days | N | N | 310008145 | CHOP |
| 310010355 | 310009545 | null | 62.7 | Adjuvant (A) | 2015-04-14 | 2015-04-15 | Bevacizumab | N | null | 310008168 | BEVACIZUMAB |
| 310010356 | 310003855 | 1.84 | 53.6 | Palliative (P) | 2015-07-29 | 2015-08-20 | CARBOPLATIN + GEMCITABINE | null | N | 310008213 | GEMCARBO |
| 310010357 | 310003859 | 1.63 | 71.2 | Curative (C) | 2016-08-25 | 2016-08-28 | Trial Unspecified | 1 | N | 310008309 | TRIAL |
| 310010358 | 310003863 | 1.73 | null | Palliative (P) | null | 2017-11-24 | CARBOPLATIN + GEMCITABINE | N | null | 310008330 | GEMCARBO |
| 310010359 | 310007589 | 1.89 | 71.9 | Palliative (P) | 2015-04-24 | 2015-05-03 | Bevacizumab | 02 | N | 310008352 | BEVACIZUMAB |
| 310010360 | 310003866 | 1.64 | 59.5 | Curative (C) | 2018-01-19 | 2018-01-19 | CHEMO-T TRIAL | 02 | N | 310008352 | TRIAL |
| 310010361 | 310003871 | 1.69 | 59 | Curative (C) | 2017-01-31 | 2017-06-21 | Bevacizumab 7.5mg/kg | 02 | N | 310008462 | BEVACIZUMAB |
| 310010364 | 310007603 | 1.59 | 82.5 | Curative (C) | 2015-06-30 | 2015-07-04 | CHEMO-T TRIAL | 2 | null | 310008649 | TRIAL |
| 310010365 | 310003895 | 1.6 | 72.8 | Curative (C) | 2017-07-10 | 2017-07-10 | Trial Unspecified | 02 | null | 310008691 | TRIAL |
| 310010366 | 310003901 | 1.76 | 84.4 | Palliative (P) | 2017-04-11 | 2017-04-11 | Liposomal Doxorubicin 40mg/m2 | N | N | 310008727 | LIPOSOMAL DOXORUBICIN |
| 310010367 | 310003902 | 1.57 | 102 | Palliative (P) | 2016-06-29 | 2016-07-07 | CARBOPLATIN + GEMCITABINE | N | N | 310008728 | GEMCARBO |
| 310010368 | 310003905 | 1.76 | 74.7 | Palliative (P) | 2016-06-17 | 2016-06-22 | Bevacizumab 7.5mg/kg | 2 | N | 310008767 | BEVACIZUMAB |
| 310010369 | 310003907 | 1.7 | 82 | Adjuvant (A) | null | 2013-12-02 | Bevacizumab | 02 | null | 310008825 | BEVACIZUMAB |
| 310010370 | 310003909 | 1.51 | 92 | Palliative (P) | 2017-07-02 | 2017-07-12 | Liposomal Doxorubicin (Caelyx) | 02 | N | 310008825 | LIPOSOMAL DOXORUBICIN |
| 310010372 | 310003914 | 0 | 42 | Curative (C) | 2015-03-11 | 2015-03-29 | STS Rhabdo VIT0910 Vinc Irino Temoz | N | N | 310008857 | NOT MATCHED |
| 310010373 | 310011186 | 1.55 | 132.8 | Palliative (P) | 2018-12-20 | 2018-12-20 | Carboplatin + Liposomal Doxorubicin | N | N | 310008897 | CARBOPLATIN + LIPOSOMAL DOX |
| 310010375 | 310003922 | 1.57 | 57 | Palliative (P) | 2017-11-24 | 2017-12-11 | Carboplatin + Liposomal Doxorubicin | N | N | 310009019 | CARBOPLATIN + LIPOSOMAL DOX |
| 310010376 | 310003924 | 1.84 | 131 | Curative (C) | 2015-05-13 | 2015-05-13 | IVE | 02 | N | 310009079 | IVE |
| 310010377 | 310007613 | 1.59 | 52.6 | Palliative (P) | 2018-12-27 | 2018-12-28 | Gemcitabine weekly | N | N | 310009084 | GEMCITABINE |
| 310010379 | 310007618 | 1.74 | null | Curative (C) | 2016-05-24 | 2016-05-27 | Gemcitabine weekly | N | N | 310009227 | GEMCITABINE |
| 310010380 | 310007619 | 1.14 | 101 | Palliative (P) | 2018-05-28 | 2018-06-03 | Carboplatin + Liposomal Doxorubicin | N | N | 310009231 | CARBOPLATIN + LIPOSOMAL DOX |
| 310010381 | 310003937 | 1.66 | 15 | Palliative (P) | 2015-07-24 | 2015-07-24 | GEM-P | 02 | N | 310009285 | GEMCITABINE + PACLITAXEL |
| 310010382 | 310003938 | null | 83.6 | Palliative (P) | 2014-12-10 | 2015-02-12 | PEMBROLIZUMAB | N | N | 310009386 | PEMBROLIZUMAB |
| 310010384 | 310003945 | null | 54.3 | Palliative (P) | 2017-04-03 | 2017-04-03 | PEMBROLIZUMAB | null | Y | 310009430 | PEMBROLIZUMAB |
| 310010385 | 310003948 | 1.57 | 60.2 | Palliative (P) | 2017-06-05 | 2017-11-22 | Carboplatin + Liposomal Doxorubicin | N | N | 310009438 | CARBOPLATIN + LIPOSOMAL DOX |
| 310010386 | 310007626 | 1.81 | null | Palliative (P) | 2015-09-02 | 2015-10-05 | CISPLATIN + GEMCITABINE | 02 | N | 310009534 | CISPLATIN + GEMCITABINE |
| 310010387 | 310003951 | null | 71.15 | Palliative (P) | 2016-03-06 | 2016-03-06 | ALCL ALCL 99 Closed AM 1, 2 or 3 | N | null | 310009598 | NOT MATCHED |
| 310010388 | 310003954 | 1.74 | 76 | Curative (C) | 2018-09-04 | 2018-11-06 | BEAM | N | N | 310009650 | BEAM |
| 310010389 | 310003956 | 1.5 | null | Not known (9) | 2015-03-20 | 2015-05-16 | Cisplatin + Gemcitabine (D 1 & 8) | N | N | 310009679 | CISPLATIN + GEMCITABINE |
| 310010390 | 310003961 | 1.65 | 90.8 | Palliative (P) | 2015-09-04 | 2015-09-04 | Brentuximab | N | N | 310009723 | BRENTUXIMAB |
| 310010391 | 310003963 | 1.6 | 57 | Palliative (P) | 2017-11-08 | 2018-04-14 | PEMBROLIZUMAB | N | N | 310009738 | PEMBROLIZUMAB |
| 310010392 | 310007633 | 1.7 | 96.6 | Curative (C) | null | 2018-01-30 | BEAM | N | N | 310009892 | BEAM |
| 310010393 | 310003969 | 1.62 | 85 | Palliative (P) | 2018-09-05 | 2018-09-05 | Brentuximab Vedotin | Y | null | 310010069 | BRENTUXIMAB |
| 310010394 | 310003973 | 1.51 | 80 | Adjuvant (A) | 2017-02-06 | 2017-02-09 | Gemcitabine weekly | N | N | 310010225 | GEMCITABINE |
| 310010395 | 310003980 | 1.53 | 61.4 | Adjuvant (A) | 2017-01-11 | 2017-01-23 | Carboplatin + Liposomal Doxorubicin | N | null | 310010231 | CARBOPLATIN + LIPOSOMAL DOX |
| 310010396 | 310007640 | null | 60.5 | Palliative (P) | 2018-10-23 | 2018-10-26 | GEMCITABINE | 2 | N | 310010243 | GEMCITABINE |